Menu
Currency
GWAS Study

Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci.

Betz RC, Petukhova L, Ripke S et al.

25608926 PubMed ID
GWAS Study Type
10585 Participants
40 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BR
Betz RC
PL
Petukhova L
RS
Ripke S
HH
Huang H
MA
Menelaou A
RS
Redler S
BT
Becker T
HS
Heilmann S
YT
Yamany T
DM
Duvic M
HM
Hordinsky M
ND
Norris D
PV
Price VH
MJ
Mackay-Wiggan J
DJ
de Jong A
DG
DeStefano GM
MS
Moebus S
BM
Böhm M
BU
Blume-Peytavi U
WH
Wolff H
LG
Lutz G
KR
Kruse R
BL
Bian L
AC
Amos CI
LA
Lee A
GP
Gregersen PK
BB
Blaumeiser B
AD
Altshuler D
CR
Clynes R
DB
de Bakker PIW
NM
Nöthen MM
DM
Daly MJ
CA
Christiano AM
Chapter II

Abstract

Summary of the research findings

Alopecia areata (AA) is a prevalent autoimmune disease with 10 known susceptibility loci. Here we perform the first meta-analysis of research on AA by combining data from two genome-wide association studies (GWAS), and replication with supplemented ImmunoChip data for a total of 3,253 cases and 7,543 controls. The strongest region of association is the major histocompatibility complex, where we fine-map four independent effects, all implicating human leukocyte antigen-DR as a key aetiologic driver. Outside the major histocompatibility complex, we identify two novel loci that exceed the threshold of statistical significance, containing ACOXL/BCL2L11(BIM) (2q13); GARP (LRRC32) (11q13.5), as well as a third nominally significant region SH2B3(LNK)/ATXN2 (12q24.12). Candidate susceptibility gene expression analysis in these regions demonstrates expression in relevant immune cells and the hair follicle. We integrate our results with data from seven other autoimmune diseases and provide insight into the alignment of AA within these disorders. Our findings uncover new molecular pathways disrupted in AA, including autophagy/apoptosis, transforming growth factor beta/Tregs and JAK kinase signalling, and support the causal role of aberrant immune processes in AA.

2,332 European ancestry cases and 5,233 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

10585
Total Participants
GWAS
Study Type
Yes
Replicated
764 European ancestry cases and 2,256 European ancestry controls
Replication Participants
European
Ancestry
U.S., Belgium, Germany
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.